Autophagy Modulation in Disease Therapy: Where Do We Stand?
about
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsmiR-Let7A Modulates Autophagy Induction in LPS-Activated MicrogliaTriptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy Pathway
P2860
Autophagy Modulation in Disease Therapy: Where Do We Stand?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@en
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@nl
type
label
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@en
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@nl
prefLabel
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@en
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@nl
P2860
P1476
Autophagy Modulation in Disease Therapy: Where Do We Stand?
@en
P2093
John J Shacka
Michael P Nelson
P2860
P2888
P304
P356
10.1007/S40139-013-0032-9
P577
2013-12-01T00:00:00Z